Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial

Mark A. Marzinke, Sybil Hosek, Zhe Wang et al.|The Lancet HIV|2023

Cited by 14